Predicting rectal cancer treatment response using MRI
Part of Cancer, Digestive system clinical trials.
This study uses advanced MRI scanning and computer analysis to predict how well rectal cancer might respond to treatments given before surgery. It may help doctors choose the best approach for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a new diagnosis of rectal adenocarcinoma and have not had any treatment yet.
- You plan to have surgery that removes the entire tumor at this hospital.
- You need a high-quality rectal MRI scan within two weeks before your surgery.
- You cannot have any other cancers or serious diseases.
- You must have complete medical records and be available for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special scan called PET/MRI to see how well treatment works for locally advanced rectal cancer before surgery. It may help doctors choose the best treatment plan for you.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This study uses MRI scans to predict whether rectal cancer has gone away completely after chemoradiation. It could help patients and doctors decide on the next treatment step, such as surgery or a watch-and-wait approach.
Hear when a new Rectal Cancer, Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.